Adani Enterprises Quarterly Q4 Results 2023
Good morning!
Here are the top stories to start your day.
For more updates on F&O, click here.
⭐Adani Enterprises Q4 profit zooms
The net profit of the ** Adani Enterprises** Group's flagship company increased by 137% YoY to ₹722 crore compared to ₹304 crore in Q42022. Similarly, its revenue increased by 26% to ₹31,346 crore on account of strong performance by Integrated Resource Management (IRM) and Airports business. The company’s board has approved a dividend of ₹1.20 a share. Click ** here** to know more.
⭐ Zydus Lifesciences gets USFDA approval
The pharma major received final USFDA approval to manufacture and market an ulcer drug known as Sucralfate USP, 1 gram. According to IQVIA data quoted by ** Zydus**, Sucralfate Tablets has annual sales of $84 million in the United States.
⭐ Blue Star reports robust Q4 numbers
The appliances company posted a net profit of ₹225 crores compared to ₹76 crores in Q4FY22. This exceptional profit growth of 195% is attributed to the sale of a land parcel. Meanwhile, the company posted quarterly revenue of ₹2,623 crore, a rise of 16% YoY. The company’s board has recommended a dividend of ₹12 per equity share.
Global markets (at 8:45 AM today)
| Indices | Today's movement |
| --
| --
- | --
- |
| SGX Nifty | ▼ 0.35% |
| Nikkei 225 (Japan) | **▲**0.12% |
| Hang Seng (Hong Kong) | **▲**0.67% |
| SSE Composite (China) | ▼ 0.59% |
| Dow Jones (US) (May 04) | ▼ 0.86% |
| NYSE (US) (May 04) | ▼ 0.99% |
| Nasdaq (US) May 04) | ▼ 0.49% |
| S&P 500 (US) (May 04) | ▼ 0.72% |
Fact of the day
Coal India plans to invest ₹91,000 crore in various projects by FY26